Nuclear medicine treatment cures lethal form of ovarian cancer in preclinical setting
bySociety of Nuclear MedicineMinimal to mild radiation nephropathy was observed in mice treated with 1 (37 kBq) or 2 (74 kBq) cycles of HER2225Ac-PRIT. Shown is representative hematoxylin
Updated on: January 18,2024
11

Nuclear medicine treatment cures lethal form of ovarian cancer in preclinical setting
bySociety of Nuclear MedicineMinimal to mild radiation nephropathy was observed in mice treated with 1 (37 kBq) or 2 (74 kBq) cycles of HER2225Ac-PRIT. Shown is representative hematoxylin
Updated on:January 18,2024
11
